
The deal is Biogen’s latest move to grow its business through acquisitions, with a particular focus on immunology. Biogen said Tuesday that it would buy Apellis Pharmaceuticals for an upfront pa...
The deal is Biogen’s latest move to grow its business through acquisitions, with a particular focus on immunology. Biogen said Tuesday that it would buy Apellis Pharmaceuticals for an upfront pa...